Interleukin-10 in serous ovarian carcinoma cell lines

Cancer Immunology, Immunotherapy

Volumn 50, Issue 6, 2001, Pages 328-333

  Berger, S ^a   Siegert, A ^a   Denkert, C ^a   Kobel M ^a   Hauptmann, S ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Interleukin 10; Ovarian cancer

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASCITES; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IN VITRO STUDY; OVARY ADENOCARCINOMA; PRIORITY JOURNAL;

CYSTADENOCARCINOMA, SEROUS; DINOPROSTONE; FEMALE; HUMANS; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; OVARIAN NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0034892070     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620100196     Document Type: Article

References (24)

1. Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: Modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells
2. Differential effects of an immunosuppressive fraction from ascites fluid of patients with ovarian cancer on spontaneous and antibody- dependent cytotoxicity
3. Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes
4. Macrophage deactivation by interleukin 10
5. A cytokine profile of normal and malignant ovary
6. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase
7. Anti-tumor and immunomodulatory activity of intraperitoneal IFN-gamma in ovarian carcinoma patients with minimal residual tumor after chemotherapy
8. IL-1 and IL-6 release by tumor-associated macrophages from human ovarian carcinoma
9. Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers
10. Regulation of tumor growth and metastasis by interleukin-10: The melanoma experience
11. Distinct patterns of expression of interleukin-1 alpha and beta by normal and cancerous human ovarian tissues
12. Tumor-host interaction: Analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas
13. Role of vascular endothelial growth factor in ovarian cancer: Inhibition of ascites information by immunoneutralization
14. Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines
15. In situ detection of tumour necrosis factor in human ovarian cancer specimens
16. Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression
17. Effects of interleukin-6 on in vitro cell attachment, migration and invasion of human ovarian carcinoma
18. Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies
19. Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors
20. Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines
21. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors
22. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures
23. Growth inhibition of ovarian cancer cells induced by antisense IL-6 oligonucleotides
24. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: Monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression